Tilray Brands TLRY
NASDAQ TLRY
$4.59 -0.24 (-4.97%)
At close: Aug 20, 2026 · 1:56 PM UTC

Tilray Brands (TLRY) Cash & Current Investments (2017 - 2026)

Tilray Brands' (TLRY) quarterly Cash & Current Investments came in at $234.6 million in Q2 2026, down 8.48% YoY from $256.4 million in Q2 2025, and up 6.68% on a QoQ basis from $219.9 million in Q1 2026.

Tilray Brands (TLRY) Cash & Current Investments (2017 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 10 years of Cash & Current Investments data on file, last reported at $234.6 million in Q2 2026.

  • Quarterly Cash & Current Investments fell 8.48% year-over-year to $234.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $234.6 million (down 8.48% YoY) and the FY2026 annual result came in at $234.6 million, down 8.48% from the prior year.
  • Cash & Current Investments grew to $234.6 million in Q2 2026, from $219.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $490.6 million in Q3 2022 to a low of $219.9 million in Q1 2026.
  • A 5-year average of $322.7 million and a median of $279.2 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments jumped 46.23% — and 2024, when it tumbled 44.68%.
  • Tracing TLRY's Cash & Current Investments over 5 years: stood at $433.5 million in 2022, then slumped by 40.07% to $259.8 million in 2023, then decreased by 2.9% to $252.2 million in 2024, then advanced by 15.58% to $291.6 million in 2025, then dropped by 19.52% to $234.6 million in 2026.
  • The last three Cash & Current Investments figures came in at $234.6 million (Q2 2026), $219.9 million (Q1 2026), and $291.6 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn 3.66 Bn
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - 164.00 Mn
10 Tilray Brands 513.87 Mn 279.24 Mn 90.52 Mn 234.63 Mn

Historic Data

Download Data
DateValue
May 31, 2026 234.63 Mn
Feb 28, 2026 219.93 Mn
Nov 30, 2025 291.55 Mn
Aug 31, 2025 264.83 Mn
May 31, 2025 256.36 Mn
Nov 30, 2024 252.25 Mn
Aug 31, 2024 280.06 Mn
May 31, 2024 260.52 Mn
Feb 29, 2024 225.86 Mn
Nov 30, 2023 259.79 Mn
Aug 31, 2023 464.85 Mn
May 31, 2023 448.53 Mn
Feb 28, 2023 408.28 Mn
Nov 30, 2022 433.50 Mn
Aug 31, 2022 490.64 Mn
May 31, 2022 415.91 Mn
Feb 28, 2022 279.21 Mn
Nov 30, 2021 331.78 Mn
Aug 31, 2021 376.30 Mn
May 31, 2021 488.47 Mn